Log in to save to my catalogue

Danaparoid sodium-based anticoagulation therapy for portal vein thrombosis in cirrhosis patients

Danaparoid sodium-based anticoagulation therapy for portal vein thrombosis in cirrhosis patients

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_23744c8be19045b6b2ffe832f426365e

Danaparoid sodium-based anticoagulation therapy for portal vein thrombosis in cirrhosis patients

About this item

Full title

Danaparoid sodium-based anticoagulation therapy for portal vein thrombosis in cirrhosis patients

Publisher

England: BioMed Central Ltd

Journal title

BMC gastroenterology, 2019-12, Vol.19 (1), p.217-217, Article 217

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Portal vein thrombosis (PVT) is a common complication of cirrhosis. However, in patients with PVT and cirrhosis, there is no clear evidence supporting effective treatment modalities. In this study, we examined the effectiveness and safety of anticoagulation therapy using danaparoid sodium for PVT in patients with cirrhosis.
This retrospective st...

Alternative Titles

Full title

Danaparoid sodium-based anticoagulation therapy for portal vein thrombosis in cirrhosis patients

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_23744c8be19045b6b2ffe832f426365e

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_23744c8be19045b6b2ffe832f426365e

Other Identifiers

ISSN

1471-230X

E-ISSN

1471-230X

DOI

10.1186/s12876-019-1140-8

How to access this item